Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annemergmed.2024.09.001DOI Listing

Publication Analysis

Top Keywords

andexanet alpha
4
alpha improve
4
improve outcomes
4
outcomes compared
4
compared four-factor
4
four-factor prothrombin
4
prothrombin complex
4
complex concentrate
4
concentrate reversal
4
reversal direct
4

Similar Publications

Article Synopsis
  • A 61-year-old man with a history of COPD, ongoing anticoagulant therapy, and pneumonia was admitted to the emergency department in critical condition due to chest pain and shortness of breath.
  • A chest X-ray and CT scan revealed a large mediastinal hematoma, rib fractures, and significant blood loss requiring urgent reversal of his anticoagulant medication before surgery.
  • After an emergency sternotomy to evacuate the hematoma, the patient made a full recovery, highlighting the importance of imaging in older patients with fall-related injuries and the need for careful management of anticoagulants.
View Article and Find Full Text PDF

The effects between andexanet alpha and four-factor prothrombin complex concentrate on DOACs anticoagulation reversal.

Crit Care

November 2024

Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning Province, China.

View Article and Find Full Text PDF

Antithrombin and tissue factor pathway inhibitor (TFPI) provide different anticoagulant mechanisms. Having established a potent anticoagulant role of cultured human umbilical vein endothelial cells in vessel-on-a-chip microfluidic models, we now investigated how these cells modulated thrombin generation under stasis through antithrombin and TFPI pathways. We observed that endothelial monolayers in 96 well-plates strongly delayed and suppressed the thrombin generation process induced by tissue factor, regardless of the presence of whole blood, platelet-rich plasma or platelet-free plasma.

View Article and Find Full Text PDF

Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review.

JAMA

September 2024

Department of Medicine, Anticoagulation and Clinical Thrombosis Service, Northwell Health at Lenox Hill Hospital, New York, New York.

Importance: Direct oral anticoagulants (DOACs), comprising apixaban, rivaroxaban, edoxaban, and dabigatran, are commonly used medications to treat patients with atrial fibrillation and venous thromboembolism. Decisions about how to manage DOACs in patients undergoing a surgical or nonsurgical procedure are important to decrease the risks of bleeding and thromboembolism.

Observations: For elective surgical or nonsurgical procedures, a standardized approach to perioperative DOAC management involves classifying the risk of procedure-related bleeding as minimal (eg, minor dental or skin procedures), low to moderate (eg, cholecystectomy, inguinal hernia repair), or high risk (eg, major cancer or joint replacement procedures).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!